Please select the location that matches your preferences
Optimise your corporate tax liability with Belgium’s Innovation Income Deduction (IID). Leyton’s tax and IP specialists help companies across all sectors identify qualifying intellectual property, calculate the maximum deduction and manage full compliance from eligibility assessment to advance ruling and filing.
HOW IT WORKS
The Innovation Income Deduction (IID) allows Belgian companies to deduct up to 85% of their net qualifying IP income from their taxable base — reducing the effective corporate tax rate on innovation income to 3.75%, one of the most competitive rates in Europe.
The IID replaced the former Patent Income Deduction (PID) and significantly broadened eligibility to cover a wide range of intellectual property rights developed through R&D activities.
It applies to Belgian companies and foreign companies with a permanent establishment in Belgium, regardless of size or sector. Unused deductions can be carried forward indefinitely, and from assessment year 2025, companies may also convert unutilised IID into a non-refundable tax credit for carryforward — a key update under the May 2024 reform.
How it helps
Leadership, Quantified
Clients supported worldwide
Years of Expertise
Countries
Tax, finance and technical experts
Funding
expertise across European
programmes
How it helps
Income generated from copyright-protected software qualifies, provided it results from a recognised R&D project validated by BELSPO under Article 275/3 of the Income Tax Code.
Royalties, licensing fees and income from the use or sale of patents and supplementary protection certificates developed through eligible R&D activities qualify for the 85% IID deduction.
Proceeds from licensing qualifying IP rights to third parties or group companies, income from IP infringement compensation, and proceeds from selling qualifying IP rights are all eligible.
Income equivalent attributed to the in-house use of qualifying software or patented technology within your own business operations may also qualify under the IID framework.
Plant breeders’ rights applied for or acquired after 30 June 2016, data exclusivity and orphan drug designations for the first ten years in the European Register are eligible qualifying IP rights.
The IID can also apply provisionally to IP rights still in the process of being obtained — including patent applications — allowing companies to benefit during the development and commercialisation phase before formal registration.
Your Path to Success
A structured IID strategy helps you identify every qualifying IP asset, calculate the optimal deduction and manage full compliance across your innovation lifecycle.
Identify qualifying IP assets, eligible R&D activities, and revenue streams that can benefit from the Innovation Income Deduction in Belgium.
Calculate your deduction base using the modified nexus approach — including the 30% uplift on qualifying R&D expenditure — and estimate your potential tax saving.
Develop complete technical and financial justification files, including BELSPO validation requests for copyright-protected software where required.
Coordinate advance ruling requests with the Belgian Tax Authorities to secure legal certainty on your IID application and manage the implementation in your corporate tax return.
Maintain accuracy in accounting records, monitor legislative developments and ensure continued compliance across subsequent financial years and IP commercialisation cycles.
Claim With Leyton
Ready to reduce your corporate tax burden through Belgium’s Innovation Income Deduction?
Book a free assessment with Leyton’s Innovation Tax & IP specialists and discover how to unlock the full fiscal value of your intellectual property.
FAQ
Everything you need to know before working with us.
The Innovation Income Deduction (IID) allows Belgian companies to deduct up to 85% of their net qualifying IP income from their taxable base, reducing the effective corporate tax rate on that income to 3.75%. It is based on the OECD modified nexus approach and replaced the former Patent Income Deduction regime.
Any company subject to Belgian corporate income tax — or a foreign company with a permanent establishment in Belgium — that develops and commercialises qualifying intellectual property through eligible R&D activities can benefit from the IID, regardless of size or sector.
Qualifying IP rights include patents, supplementary protection certificates, copyright-protected software validated by BELSPO, plant breeders’ rights, data exclusivity rights and orphan drug designations. A provisional application also applies to IP rights still being obtained.
The IID is calculated as 85% of net qualifying IP income, multiplied by a nexus fraction: own R&D expenditure (uplifted by 30%) divided by total R&D expenditure. This ensures the benefit is proportional to the company’s own research effort.
Yes, provided it results from a recognised R&D project validated by the Belgian Science Policy Office (BELSPO) under Article 275/3 of the Income Tax Code. Leyton manages the BELSPO validation process and coordinates with the tax authorities on your behalf.
From assessment year 2025, companies may choose not to apply part or all of their IID against their taxable base and instead convert the unutilised amount into a non-refundable tax credit for carryforward. This option is particularly relevant for companies subject to Pillar Two minimum tax rules but is available to all corporate taxpayers.
Yes. If there is insufficient taxable profit to absorb the full IID in a given year, the unused deduction can be carried forward indefinitely to future taxable periods.
An advance ruling from the Belgian Tax Authorities provides legal certainty on the application of the IID to your specific IP assets — ensuring your deduction is fully defensible, compliant and protected in case of audit across multi-year IP commercialisation cycles.
Yes. The IID can be used alongside the partial withholding tax exemption for R&D researchers and, in certain configurations, the Investment Deduction — allowing companies to build a comprehensive, complementary fiscal strategy across their full innovation investment cycle.
Leyton’s multidisciplinary team — combining tax lawyers, PhD scientific consultants and IP specialists — audits your full R&D and IP portfolio, calculates the optimal nexus-based deduction, manages BELSPO validation for software, coordinates advance ruling requests and handles filing and ongoing compliance. Our expertise spans the full IID lifecycle, from eligibility to audit defence.